Citius Pharmaceuticals, Inc. (CTXR) Starts Presentation at LD Micro Conference

Specializing in the development and commercialization of therapeutic products, Citius Pharmaceuticals, Inc. (OTC: CTXR) employs innovative, patented or proprietary formulations of previously approved pharmaceutical products for emerging markets. The company aims to find new and expanded ideas for previously approved pharmaceutical products as a means to achieve leading market positions or potential market exclusivity. By using previously approved drugs with substantial safety and efficacy data, Citius intends to reduce the risks associated with pharmaceutical product development. For more information, visit the company’s website at www.citiuspharma.com.